Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Nivolumab × Thoracic × Clear all

Phase

Status

Sponsor Class

OTHER 138 INDUSTRY 128 NIH 6 OTHER_GOV 4 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 2 Palliative Care 2 stenoparib 1 poly ICLC 1 pasireotide 1 leucoselect phytosome 1 Waiting Lists 1 Topotecan 1 Temozolomide 1 Radiosurgery 1 PM 01183 1 Nivolumab 1 Immunoglobulins, Intravenous 1 Focus Groups 1 Exercise Therapy 1 Enalapril 1 Diet 1 Control Groups 1 Cognitive Behavioral Therapy 1 Celecoxib 1 Behavior Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06275360 2026-03-02

RIVAL

VA Office of Research and Development

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡